Clouse WD, Hallett JW Jr, Schaff HV, Gayari MM, Ilstrup DM, Melton LJ 3rd. Improved prognosis of thoracic aortic aneurysms: a population-based study. JAMA. 1998;280(22):1926–9.
Article CAS PubMed Google Scholar
Elefteriades JA. Thoracic aortic aneurysm: reading the enemy’s playbook. Yale J Biol Med. 2008;81(4):175–86.
PubMed PubMed Central Google Scholar
Senser EM, Misra S, Henkin S. Thoracic aortic aneurysm: a clinical review. Cardiol Clin. 2021;39(4):505–15.
Mori M, Yousef S, Zhuo H, Bin Mahmood SU, Mojibian H, Zhang Y, Geirsson A. Diabetes and hypertension associate differently with the risk of ascending thoracic aortic aneurysm: a CT study of 21,295 patients. JACC Cardiovasc Imaging. 2020;13(7):1634–6.
Prakash SK, Pedroza C, Khalil YA, Milewicz DM. Diabetes and reduced risk for thoracic aortic aneurysms and dissections: a nationwide case-control study. J Am Heart Assoc. 2012. https://doi.org/10.1161/JAHA.111.000323.
Article PubMed PubMed Central Google Scholar
D’Cruz RT, Wee IJY, Syn NL, Choong A. The association between diabetes and thoracic aortic aneurysms. J Vasc Surg. 2019;69(1):263-268 e261.
Golledge J, Karan M, Moran CS, Muller J, Clancy P, Dear AE, Norman PE. Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions. Eur Heart J. 2008;29(5):665–72.
Article CAS PubMed Google Scholar
Aune D, Schlesinger S, Norat T, Riboli E. Diabetes mellitus and the risk of abdominal aortic aneurysm: a systematic review and meta-analysis of prospective studies. J Diabetes Complications. 2018;32(12):1169–74.
Krizhanovskii C, Franco-Cereceda A. Diabetes, incretin therapy and thoracic aortic aneurysm—what does the evidence show? Curr Vasc Pharmacol. 2019;17(5):432–9.
Article CAS PubMed Google Scholar
Arun D, Munir W, Schmitt LV, Vyas R, Ravindran JI, Bashir M, Williams IM, Velayudhan B, Idhrees M. Exploring the correlation and protective role of diabetes mellitus in aortic aneurysm disease. Front Cardiovasc Med. 2021;8: 769343.
Article CAS PubMed PubMed Central Google Scholar
Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017;318(19):1925–6.
Burgess S, Scott RA, Timpson NJ, Davey Smith G, Thompson SG. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol. 2015;30(7):543–52.
Article PubMed PubMed Central Google Scholar
Morris DR, Jones GT, Holmes MV, Bown MJ, Bulbulia R, Singh TP, Golledge J. Genetic predisposition to diabetes and abdominal aortic aneurysm: a two stage Mendelian randomisation study. Eur J Vasc Endovasc Surg. 2022;63(3):512–9.
van ’t Hof FN, Vaucher J, Holmes MV, de Wilde A, Baas AF, Blankensteijn JD, Hofman A, Kiemeney LA, Rivadeneira F, Uitterlinden AG, et al. Genetic variants associated with type 2 diabetes and adiposity and risk of intracranial and abdominal aortic aneurysms. Eur J Hum Genet. 2017;25(6):758–62.
Xue A, Wu Y, Zhu Z, Zhang F, Kemper KE, Zheng Z, Yengo L, Lloyd-Jones LR, Sidorenko J, Wu Y, et al. Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nat Commun. 2018;9(1):2941.
Article PubMed PubMed Central Google Scholar
Soranzo N, Sanna S, Wheeler E, Gieger C, Radke D, Dupuis J, Bouatia-Naji N, Langenberg C, Prokopenko I, Stolerman E, et al. Common variants at 10 genomic loci influence hemoglobin A(1)(C) levels via glycemic and nonglycemic pathways. Diabetes. 2010;59(12):3229–39.
Article CAS PubMed PubMed Central Google Scholar
Chen J, Spracklen CN, Marenne G, Varshney A, Corbin LJ, Luan J, Willems SM, Wu Y, Zhang X, Horikoshi M, et al. The trans-ancestral genomic architecture of glycemic traits. Nat Genet. 2021;53(6):840–60.
Article CAS PubMed PubMed Central Google Scholar
Morris AP, Voight BF, Teslovich TM, Ferreira T, Segre AV, Steinthorsdottir V, Strawbridge RJ, Khan H, Grallert H, Mahajan A, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44(9):981–90.
Article CAS PubMed PubMed Central Google Scholar
Pirruccello JP, Chaffin MD, Chou EL, Fleming SJ, Lin H, Nekoui M, Khurshid S, Friedman SF, Bick AG, Arduini A, et al. Deep learning enables genetic analysis of the human thoracic aorta. Nat Genet. 2022;54(1):40–51.
Article CAS PubMed Google Scholar
Palmer TM, Lawlor DA, Harbord RM, Sheehan NA, Tobias JH, Timpson NJ, Davey Smith G, Sterne JA. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res. 2012;21(3):223–42.
Article PubMed PubMed Central Google Scholar
Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658–65.
Article PubMed PubMed Central Google Scholar
Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304–14.
Article PubMed PubMed Central Google Scholar
Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512–25.
Article PubMed PubMed Central Google Scholar
Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693–8.
Article CAS PubMed PubMed Central Google Scholar
Hemani G, Tilling K, Davey Smith G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 2017;13(11): e1007081.
Article PubMed PubMed Central Google Scholar
Liu B, Mason AM, Sun L, Di Angelantonio E, Gill D, Burgess S. Genetically predicted type 2 diabetes mellitus liability, glycated hemoglobin and cardiovascular diseases: a wide-angled Mendelian randomization study. Genes. 2021;12(10):1644.
Article CAS PubMed PubMed Central Google Scholar
Suzuki Y, Kaneko H, Yano Y, Okada A, Itoh H, Ueno K, Matsuoka S, Fujiu K, Michihata N, Jo T, et al. Dose-dependent relationship of blood pressure and glycaemic status with risk of aortic dissection and aneurysm. Eur J Prev Cardiol. 2022;29(18):2338–46.
Cohen RM, Franco RS, Khera PK, Smith EP, Lindsell CJ, Ciraolo PJ, Palascak MB, Joiner CH. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood. 2008;112(10):4284–91.
Article CAS PubMed PubMed Central Google Scholar
Yang G, Au Yeung SL, Schooling CM. Sex differences in the association of fasting glucose with HbA1c, and their consequences for mortality: a Mendelian randomization study. EBioMedicine. 2022;84: 104259.
Article CAS PubMed PubMed Central Google Scholar
Morris DR, Sherliker P, Clack R, Preiss D, Lam KBH, Carter J, Halliday A, Peto R, Lewington S, Bulbulia R. Opposite associations of aortic aneurysm with blood glucose and with diabetes mellitus. Circulation. 2019;140(3):264–6.
Golledge J, Morris DR, Pinchbeck J, Rowbotham S, Jenkins J, Bourke M, Bourke B, Norman PE, Jones R, Moxon JV. Editor’s choice—metformin prescription is associated with a reduction in the combined incidence of surgical repair and rupture related mortality in patients with abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2019;57(1):94–101.
Golledge J, Moxon J, Pinchbeck J, Anderson G, Rowbotham S, Jenkins J, Bourke M, Bourke B, Dear A, Buckenham T, et al. Association between metformin prescription and growth rates of abdominal aortic aneurysms. Br J Surg. 2017;104(11):1486–93.
Article CAS PubMed Google Scholar
Itoga NK, Rothenberg KA, Suarez P, Ho TV, Mell MW, Xu B, Curtin CM, Dalman RL. Metformin prescription status and abdominal aortic aneurysm disease progression in the US veteran population. J Vasc Surg. 2019;69(3):710-716 e713.
Fujimura N, Xiong J, Kettler EB, Xuan H, Glover KJ, Mell MW, Xu B, Dalman RL. Metformin treatment status and abdominal aortic aneurysm disease progression. J Vasc Surg. 2016;64(1):46-54 e48.
Article PubMed PubMed Central Google Scholar
Kaya MG, Calapkorur B, Karaca Z, Yildirim S, Celik A, Akpek M, Unluhizarci K, Kelestimur F. The effects of treatment with drospirenone/ethinyl oestradiol alone or in combination with metformin on elastic properties of aorta in women with polycystic ovary syndrome. Clin Endocrinol. 2012;77(6):885–92.
留言 (0)